Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) Director Jeanne Quirk sold 1,789 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $140.22, for a total transaction of $250,853.58. Following the completion of the sale, the director directly owned 11,400 shares in the company, valued at $1,598,508. This represents a 13.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Axcelis Technologies Trading Up 4.4%
Shares of ACLS traded up $6.33 during mid-day trading on Wednesday, hitting $149.56. The company had a trading volume of 386,214 shares, compared to its average volume of 781,032. The business’s 50-day simple moving average is $117.06 and its 200-day simple moving average is $96.90. The company has a quick ratio of 2.99, a current ratio of 4.59 and a debt-to-equity ratio of 0.04. Axcelis Technologies, Inc. has a 1-year low of $55.93 and a 1-year high of $171.61. The stock has a market cap of $4.60 billion, a PE ratio of 46.59, a P/E/G ratio of 11.64 and a beta of 1.93.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last released its earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The business had revenue of $198.96 million for the quarter, compared to analysts’ expectations of $195.03 million. During the same period last year, the company earned $0.88 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Sell-side analysts forecast that Axcelis Technologies, Inc. will post 2.86 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several equities research analysts recently issued reports on ACLS shares. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price on the stock in a research report on Monday, April 20th. Weiss Ratings lowered shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Finally, Zacks Research upgraded shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Axcelis Technologies presently has an average rating of “Hold” and a consensus price target of $116.25.
Get Our Latest Stock Analysis on Axcelis Technologies
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Read More
- Five stocks we like better than Axcelis Technologies
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
